Specialty code 183500000X · Sacramento, CA
NPI
1043745904
Since 2017
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6600 Bruceville Rd
Sacramento, CA, 95823
Phone (559) 361-6018
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$417K
3,557 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Myron Todd prescribed most often to Medicare patients was Atorvastatin Calcium, with 537 prescriptions and refills. In total Myron Todd wrote 3,557 Medicare prescriptions that cost $417K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 537 | 1,777 | 216 | $6,519 |
| Metformin Hcl Er Metformin Hcl | 359 | 1,185 | 153 | $3,593 |
| Glipizide Generic | 341 | 1,109 | 147 | $4,445 |
| Metformin Hcl Generic | 294 | 937 | 123 | $3,730 |
| Jardiance Empagliflozin | 172 | 541 | 66 | $92K |
| Lisinopril Generic | 166 | 537 | 65 | $1,936 |
| Amlodipine Besylate Generic | 152 | 503 | 59 | $1,821 |
| Losartan Potassium Generic | 142 | 471 | 53 | $1,903 |
| Humulin N Insulin Nph Human Isophane | 131 | 403 | 60 | $28K |
| Simvastatin Generic | 100 | 331 | 37 | $1,136 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 91 | 248 | 45 | $2,119 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 87 | 237 | 38 | $2,216 |
| Victoza 2-Pak Liraglutide | 83 | 88 | 25 | $55K |
| Humulin R Insulin Regular, Human | 77 | 235 | 30 | $15K |
| Insulin Glargine-Yfgn Generic | 76 | 207 | 47 | $12K |
Brand drugs: 813 claims; generic drugs: 2,474 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Myron Todd were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.